RT-LAMP-CRISPR-Cas13a technology as a promising diagnostic tool for the SARS-CoV-2 virus
Concha Ortiz-Cartagena, View ORCID ProfileLaura Fernández-García, View ORCID ProfileLucia Blasco, View ORCID ProfileOlga Pacios, View ORCID ProfileInés Bleriot, View ORCID ProfileMaría López, Rafael Cantón, View ORCID ProfileMaría Tomás
doi: https://doi.org/10.1101/2022.06.29.22277060
Concha Ortiz-Cartagena
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Laura Fernández-García
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Lucia Blasco
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Olga Pacios
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Inés Bleriot
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
María López
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
3Spanish Network for Research in Infectious Diseases (REIPI) and CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Rafael Cantón
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
3Spanish Network for Research in Infectious Diseases (REIPI) and CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
4Microbiology Deparment, Hospital Ramón y Cajal-IRYCIS, Madrid
María Tomás
1Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC); Microbiology Department, Hospital A Coruña (CHUAC); University of A Coruña (UDC), A Coruña, Spain
2Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
3Spanish Network for Research in Infectious Diseases (REIPI) and CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Article usage
Posted June 30, 2022.
RT-LAMP-CRISPR-Cas13a technology as a promising diagnostic tool for the SARS-CoV-2 virus
Concha Ortiz-Cartagena, Laura Fernández-García, Lucia Blasco, Olga Pacios, Inés Bleriot, María López, Rafael Cantón, María Tomás
medRxiv 2022.06.29.22277060; doi: https://doi.org/10.1101/2022.06.29.22277060
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1533)
- Respiratory Medicine (916)
- Rheumatology (441)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)